Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
1.800
-0.030 (-1.64%)
At close: Jun 11, 2025, 4:00 PM
1.740
-0.060 (-3.33%)
Pre-market: Jun 12, 2025, 8:02 AM EDT
Bluejay Diagnostics Market Cap
Bluejay Diagnostics has a market cap or net worth of $2.69 million as of June 12, 2025. Its market cap has increased by 88.98% in one year.
Market Cap
2.69M
Enterprise Value
-226.81K
1-Year Change
88.98%
Ranking
Category
Stock Price
$1.80
Market Cap Chart
Since the IPO on November 10, 2021, Bluejay Diagnostics's market cap has decreased from $67.50M to $2.69M, a decrease of -96.02%. That is a compound annual growth rate of -59.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 11, 2025 | 2.69M | 2.71% |
| Dec 31, 2024 | 2.62M | 73.26% |
| Dec 29, 2023 | 1.51M | -80.26% |
| Dec 30, 2022 | 7.66M | -84.66% |
| Dec 31, 2021 | 49.91M | -26.06% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 694.58B |
| Johnson & Johnson | 374.23B |
| AbbVie | 335.25B |
| Novo Nordisk | 332.47B |
| UnitedHealth Group | 274.14B |
| Abbott Laboratories | 232.56B |
| Novartis AG | 231.17B |
| AstraZeneca | 226.14B |